(19)
(11) EP 4 103 713 A1

(12)

(43) Date of publication:
21.12.2022 Bulletin 2022/51

(21) Application number: 21780993.8

(22) Date of filing: 12.02.2021
(51) International Patent Classification (IPC): 
C12N 15/11(2006.01)
A61P 31/16(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 31/16; C12N 15/1131; C12N 2310/11; C12N 2310/3231; C12N 2310/341; C12N 2310/113
(86) International application number:
PCT/US2021/018025
(87) International publication number:
WO 2021/201996 (07.10.2021 Gazette 2021/40)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 14.02.2020 US 202016792103
20.03.2020 US 202062992659 P

(71) Applicant: The Board of Trustees of the Leland Stanford Junior University
Stanford, CA 94305-2038 (US)

(72) Inventors:
  • GLENN, Jeffrey S.
    Palo Alto, California 94301 (US)
  • SALUTI, Rachel Hagey
    Stanford, California 94305 (US)
  • PHAM, Edward A.
    Palo Alto, California 94306 (US)

(74) Representative: Appleyard Lees IP LLP 
15 Clare Road
Halifax HX1 2HY
Halifax HX1 2HY (GB)

   


(54) PAN-GENOTYPIC AGENTS AGAINST RESPIRATORY VIRUSES AND METHODS OF USING THE SAME